Authors: KLAUSNER JD MAKONKAWKEYOON S AKARASEWI P NAKATA K KASINRERK W CORRAL L DEWAR RL LANE HC FREEDMAN VH KAPLAN G

Citation: Jd. Klausner et al., THE EFFECT OF THALIDOMIDE ON THE PATHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND MYCOBACTERIUM-TUBERCULOSIS INFECTION, Journal of acquired immune deficiency syndromes and human retrovirology, 11(3), 1996, pp. 247-257

Authors: TRAMONTANA JM UTAIPAT U MOLLOY A AKARASEWI P BURROUGHS M MAKONKAWKEYOON S JOHNSON B KLAUSNER JD ROM W KAPLAN G

Citation: Jm. Tramontana et al., THALIDOMIDE TREATMENT REDUCES TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION AND ENHANCES WEIGHT-GAIN IN PATIENTS WITH PULMONARY TUBERCULOSIS, Molecular medicine, 1(4), 1995, pp. 384-397

Authors: MAKONKAWKEYOON S SMITAMANA P HIRUNPETCHARAT C MANEEKARN N

Citation: S. Makonkawkeyoon et al., PRODUCTION OF MOUSE IMMUNOGLOBULIN-G BY A HYBRID PLANT-DERIVED FROM TOBACCO-MOUSE CELL FUSIONS, Experientia, 51(1), 1995, pp. 19-25

Authors: MAKONKAWKEYOON S LIMSONPOBRE RNR MOREIRA AL SCHAUF V KAPLAN G

Citation: S. Makonkawkeyoon et al., THALIDOMIDE INHIBITS THE REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, Proceedings of the National Academy of Sciences of the United Statesof America, 90(13), 1993, pp. 5974-5978